Polsinelli shareholder Dan E. Cranshaw
has been selected as a member of the 2016 Class of Fellows, participating in a landmark program created by the Leadership Council on Legal Diversity (LCLD). Cranshaw joins a select group of experienced attorneys from diverse backgrounds who have been recognized for their potential as leaders in their organizations.
“We’re proud of Dan and his selection as an LCLD Fellow,” said Chairman Russ Welsh
. “I feel certain that the program will enhance Dan’s role as a leader in our firm.”
The LCLD Fellows Program is a highly structured training program designed to build relationships and leadership skills, by offering its participants a unique year of in-person training, peer-group projects and extensive contact with LCLD’s top leadership. The organization consists of more than 240 corporate chief legal officers and law firm managing partners. The Fellows program, which has trained more than 800 mid-career attorneys since 2011, is one of LCLD’s most important initiatives.
“I’m very excited to be an LCLD Fellow and collaborate with my peers as we navigate the program together,” said Cranshaw. “This is a great development opportunity for me, and I’m looking forward to learning from the top leaders in the industry.”
Cranshaw works with corporate clients and/or their boards to help companies defend claims, secure coverage and grow their businesses. He focuses his practice on defending products liability and warranty claims, commercial litigation, risk management, insurance recovery and toxic tort litigation. He has been involved in class actions in state and federal courts across the United States, and has successfully dealt with all aspects of class action litigation, including pre-certification dismissals and summary judgments, class discovery, class certification and de-certification and claims administration.
This honor adds to Cranshaw’s lengthy list of achievements, including a ranking in Benchmark Litigation
and recognition by the American Board of Trial Advocates Award for Outstanding Performance in Trial Advocacy.